Infinity Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Infinity Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $2.93 per share as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2023-03-28
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.93.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.53.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.51.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.58.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2022-12-31 | $2.93 10-K · filed 2023-03-28 |
| 2021-12-31 | $3.53 10-K · filed 2023-03-28 |
| 2020-12-31 | $3.51 10-K · filed 2022-03-29 |
| 2019-12-31 | $4.58 10-K · filed 2021-03-16 |
| 2018-12-31 | $5.36 10-K · filed 2020-03-03 |
| 2017-12-31 | $6.02 10-K · filed 2019-03-14 |
| 2016-12-31 | $12.06 10-K · filed 2018-03-15 |
| 2015-12-31 | $13.73 10-K · filed 2017-03-14 |
| 2014-12-31 | $13.76 10-K · filed 2016-02-23 |
| 2013-12-31 | $14.04 10-K · filed 2015-02-24 |
| 2012-12-31 | $9.00 10-K · filed 2014-02-25 |
| 2011-12-31 | $8.34 10-K · filed 2013-03-05 |